Cargando…
Intravenous Ascorbic Acid and Lung Function in Severely Ill COVID-19 Patients
Current evidence suggests that ascorbic acid improves the host’s immune system and, therefore, may play a role in reducing the severity of infectious diseases. Coronavirus disease 2019 (COVID-19) is a potentially life-threatening viral infection that mainly infects the lungs. The objective of this r...
Autores principales: | Sokary, Sara, Ouagueni, Asma, Ganji, Vijay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505837/ https://www.ncbi.nlm.nih.gov/pubmed/36144269 http://dx.doi.org/10.3390/metabo12090865 |
Ejemplares similares
-
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
por: Wagner, Samuel C, et al.
Publicado: (2014) -
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
por: Ichim, Thomas E, et al.
Publicado: (2011) -
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
por: Fowler, Alpha A, et al.
Publicado: (2014) -
Administration of Intravenous Ascorbic Acid—Practical Considerations for Clinicians
por: Walker, Scott E., et al.
Publicado: (2019) -
Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials
por: Nauman, Gina, et al.
Publicado: (2018)